Laos generic drug osimertinib/osimertinib price

Osimertinib (Osimertinib) is an oral targeted therapy drug used to treat EGFR (epidermal growth factor receptor) gene mutation-positive advanced non-small cell lung cancer (NSCLC). As a third-generation EGFR tyrosine kinase inhibitor, osimertinib has higher selectivity and can effectively inhibit EGFR mutations and drug resistance mutations.

Osimertinib/The mechanism of action of Osimertinib is to interfere with the growth, proliferation and survival of tumor cells by inhibiting the EGFR signaling pathway, thereby inhibiting the development and metastasis of tumors. Compared with traditional chemotherapy drugs, Osimertinib/Osimertinib has higher therapeutic effect and fewer toxic side effects.

Now, the original drug of osimertinib/osimertinib has been officially launched in China and has been included in the national medical insurance catalog. Patients can conveniently purchase it in China without going abroad. Its domestic selling price is approximately in the range of 3,000 to 4,000 yuan, but for specific price information and medical insurance reimbursement policies, patients are advised to consult their local hospital pharmacy to obtain the most accurate data.

For patients looking for more affordable options, there are some generic drugs available in foreign markets. Among them, the prices of generic drugs listed in Laos and Bangladesh are particularly affordable, usually only a few hundred yuan, which is much lower than domestic prices. It is worth mentioning that these generic drugs are basically the same as the original drugs in terms of drug ingredients, so they are also a viable treatment option.

Common side effects include rash, diarrhea, drowsiness, fatigue, cough, etc. Serious adverse reactions may include interstitial pneumonia, cardiovascular events, visual impairment, etc. Patients should pay close attention to their own conditions during medication and report any symptoms of discomfort to their doctors in a timely manner.

Osimertinib/OsimertinibIt is usually administered as an oral tablet in a dose of 80 mg once a day, with or without food. Patients should take Osimertinib on time and in the correct amount under the guidance of a doctor, and should not change the dosage or stop taking the medicine at will.

In general, Osimertinib/Osimertinib, as a targeted therapy drug, has significant therapeutic effects and less toxic side effects for advanced non-small cell lung cancer with positive EGFR gene mutations. It provides patients with an effective treatment option and improves the survival rate and quality of life of patients with advanced lung cancer.